KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Current Deferred Revenue: 2018-2023

Historic Current Deferred Revenue for Tenet Healthcare (THC) over the last 6 years, with Q3 2023 value amounting to $86.0 million.

  • Tenet Healthcare's Current Deferred Revenue fell 2252.25% to $86.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $86.0 million, marking a year-over-year decrease of 2252.25%. This contributed to the annual value of $110.0 million for FY2022, which is 8852.97% down from last year.
  • According to the latest figures from Q3 2023, Tenet Healthcare's Current Deferred Revenue is $86.0 million, which was down 2252.25% from $76.0 million recorded in Q2 2023.
  • Tenet Healthcare's 5-year Current Deferred Revenue high stood at $1.3 billion for Q3 2020, and its period low was $61.0 million during Q4 2019.
  • Moreover, its 5-year median value for Current Deferred Revenue was $257.0 million (2022), whereas its average is $470.3 million.
  • In the last 5 years, Tenet Healthcare's Current Deferred Revenue soared by 178955.22% in 2020 and then crashed by 8923.38% in 2022.
  • Tenet Healthcare's Current Deferred Revenue (Quarter) stood at $61.0 million in 2019, then skyrocketed by 736.07% to $510.0 million in 2020, then surged by 88.04% to $959.0 million in 2021, then tumbled by 88.53% to $110.0 million in 2022, then decreased by 21.82% to $86.0 million in 2023.
  • Its Current Deferred Revenue stands at $86.0 million for Q3 2023, versus $76.0 million for Q2 2023 and $76.0 million for Q1 2023.